August 5, 2026European Heart Journal79 citations
BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction
View Full Paper
Key Points
- This editorial examines the limitations of BNP as a biomarker in assessing heart failure with preserved ejection fraction.
- Discussion of the findings from Verbrugge et al. regarding natriuretic peptide levels.
- Analysis of morbidity and mortality outcomes related to heart failure with preserved ejection fraction.
- Patients with normal natriuretic peptide levels still exhibit increased morbidity.
- Mortality risks are higher in patients despite normal levels of BNP, highlighting the imperfect nature of this biomarker.
Abstract
This editorial refers to ‘Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality’, by F.H. Verbrugge et al., https://doi.org/10.1093/eurheartj/ehab911.